期刊文献+

Which is the best peri-operative anti-coagulative therapy of transverse sinus stenting for refractory idiopathic intracranial hypertension? 被引量:1

Which is the best peri-operative anti-coagulative therapy of transverse sinus stenting for refractory idiopathic intracranial hypertension?
原文传递
导出
摘要 Treatment of refractory idiopathic intracranial hypertension (lIH) is a challenging problem, We reported a refractory IIH patient who manifested with typical intracranial hypertensive symptoms successfully treated with endovascular stent implantation. Pre-operative cerebrospinal fluid (CSF) opening pressure is 36 cmH2O. Cerebral angiography demonstrated a stenotic lesion located at the right transverse sinus (TS). The stenotic TS returned to its normal caliber and the pressure gradient deceased from 36 mmHg to 4 mmHg after the stent placement. The intracranial hypertensive symptoms resolved and one month later, the CSF opening pressure decreased to 14 cmH2O. Treatment of refractory idiopathic intracranial hypertension (lIH) is a challenging problem, We reported a refractory IIH patient who manifested with typical intracranial hypertensive symptoms successfully treated with endovascular stent implantation. Pre-operative cerebrospinal fluid (CSF) opening pressure is 36 cmH2O. Cerebral angiography demonstrated a stenotic lesion located at the right transverse sinus (TS). The stenotic TS returned to its normal caliber and the pressure gradient deceased from 36 mmHg to 4 mmHg after the stent placement. The intracranial hypertensive symptoms resolved and one month later, the CSF opening pressure decreased to 14 cmH2O.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2012年第16期2951-2953,共3页 中华医学杂志(英文版)
关键词 pseudotumor cerebri therapy angiography STENTS pseudotumor cerebri therapy," angiography stents
  • 相关文献

参考文献14

  • 1Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension. Neurology 2002; 59: 1492-1495.
  • 2Ko MW, Chang SC, Ridha MA, Ney J J, Ali TF, Friedman DI, et al. Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology 2011; 76: 1564-1567.
  • 3Karahalios DG, Rekate HL, Khayata MH, Apostolides PJ. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology 1996; 46: 198-202.
  • 4Farb RI, Vanek I, Scott JN, Mikulis D J, Willinsky RA, Tomlinson G, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology 2003: 60: 1418-1424.
  • 5King JO, Mitchell PJ, Thomson KR, Tress BM. Cerebral venography and manometry in idiopathic intracranial hypertension. Neurology 1995; 45: 2224-2228.
  • 6Rohr A, Dorner L, Stingele R, Buhl R, Alike K, Jansen O. Reversibility of venous sinus obstruction in idiopathicintracranial hypertension. AJNR Am J Neuroradiol 2007; 28: 656-659.
  • 7Higgins JN, Owler BK, Cousins C, Pickard JD. Venous sinus stenting for refractory benign intracranial hypertension. Lancet 2002; 359: 228-230.
  • 8Garton HJ. Cerebrospinal fluid diversion procedures. J Neuroophthalmol 2004; 24: 146-155.
  • 9Feldon SE. Visual outcomes comparing surgical techniques for management of severe idiopathic intracranial hypertension. Neurosur~ Focus 2007: 23: E6.
  • 10ldrazls I'W. Cllmcal review: the surgical treatment of idiopathic pseudotumour cerebri (idiopathic intracranial hypertension). Cephalalgia 2008; 28: 1361-1373.

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部